Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,109,878
+$1,984,445 QoQ
Shares Held
16,700
+1755.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#813
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PARADIGM ASSET MANAGEMENT CO LLC holds $12,808,040 across 10 Drug Manufacturers - General names. GILD ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,900 | $3,784,153 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
16,700 | $2,109,878 | |
| 3 | ABBV |
AbbVie Inc.
|
7,300 | $1,836,972 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,500 | $1,734,750 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,400 | $1,175,448 | |
| 6 | PFE |
Pfizer Inc
|
41,300 | $994,504 | |
| 7 | LLY |
ELI LILLY & Co
|
550 | $659,686 | |
| 8 | NVS |
Novartis AG
|
1,800 | $282,096 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,109,878 | 16,700 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $125,433 | 900 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $110,466 | 900 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $99,900 | 900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $99,783 | 900 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,187,730 | 10,600 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $979,122 | 10,600 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,567,808 | 18,700 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,283,007 | 18,700 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,717,712 | 23,450 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,944,240 | 24,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,851,018 | 24,700 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,003,820 | 26,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $356,771 | 4,300 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $369,155 | 4,300 | Shares | Sole | 2023-02-13 | |
| 2022-03-31 | $267,525 | 4,500 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $326,745 | 4,500 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $356,235 | 5,100 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $392,502 | 5,700 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $394,243 | 6,100 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $390,342 | 6,700 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $967,438 | 15,310 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,370,301 | 17,810 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,615,563 | 21,610 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||